Tech Company Financing Transactions
OWKIN Funding Round
Sanofi-Genzyme BioVentures participated in a $180 million capital raise for OWKIN. The round was announced on 11/19/2021.
Transaction Overview
Company Name
Announced On
11/19/2021
Transaction Type
Venture Equity
Amount
$180,000,000
Round
Undisclosed
Investors
Sanofi-Genzyme BioVentures (Arnaud Robert)
Proceeds Purpose
Sanofi's investment will support Owkin's development and goal to grow the world's leading histology and genomic cancer database from top oncology centers.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
831 Bdwy. 3R
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
OWKIN adresses the problem of low efficiency of pharma R&D in cancer and chronic diseases. Developing new integrative and interpretable technologies of machine learning, OWKINpharma main program harnesses pharmaceutical data such as chemical or clinical trials measurements.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Clozel
Chief Operating Officer
Anna Bondarenko
Chief Scientific Officer
Gilles Wainrib
Chief Technical Officer
Pierre Courtiol
VP - Bus. Development
Anna Huyghues-Despointes
VP - Engineering
Camille Marini
VP - Finance
Isabelle Laforgue
VP - Product Management
Mathieu Galtier
VP - R & D
Mikhail Zaslavskiy
Browse more venture capital transactions:
Prev: 11/19/2021: Nexar venture capital transaction
Next: 11/19/2021: Fountain Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs